{"product_id":"retatrutid-c","title":"Retatrutide 5mg\/10mg\/30mg","description":"\u003ch1 class=\"p1\"\u003eWhat is Retatrutide?\u003c\/h1\u003e\n\u003cp\u003eRetatrutide is a peptide analog consisting of 42 amino acids, which is a subject of scientific interest mainly in the field of metabolic regulation. A distinctive feature of the molecule is its triple receptor profile – interaction with GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide) and glucagon receptors. This combined activity distinguishes it from classic GLP-1 analogs and places it among the more extensively studied incretin compounds.\u003c\/p\u003e\n\u003cp\u003eIn scientific literature, Retatrutide is primarily discussed in relation to obesity, type 2 diabetes, and other metabolic conditions. Published clinical data describe changes in body weight, glycemic control, and various cardiometabolic indicators in observed participant groups.\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eObservations and Data on Retatrutide\u003c\/h2\u003e\n\u003cp\u003eAvailable publications examine Retatrutide in several main areas related to metabolic function, energy balance, and appetite regulation:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlucose control\u003c\/strong\u003e – clinical studies have described tendencies towards a reduction in HbA1c and an improvement in insulin sensitivity in some participants.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeight reduction\u003c\/strong\u003e – published results show a significant reduction in body weight and fat mass, with effects being more pronounced in some protocols compared to compounds with a dual receptor mechanism.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHepatic metabolism\u003c\/strong\u003e – individual studies have reported changes in hepatic steatosis, as well as improvements in some lipid profile indicators.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardiometabolic markers\u003c\/strong\u003e – changes in triglycerides, systolic blood pressure, and certain inflammatory markers have been described.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEnergy expenditure\u003c\/strong\u003e – experimental models suggest a possible influence on energy expenditure, utilization of fat stores, and mechanisms related to appetite.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eScientific publications most often describe subcutaneous administration once weekly. Various research protocols use gradual titration, with initial doses often starting at 2 mg weekly and subsequently increasing according to tolerability and observed results.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhen dissolving 5 mg with 2 ml bacteriostatic water:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe resulting concentration is 2.5 mg\/ml, meaning 0.4 ml contains 1 mg.\u003c\/p\u003e\n\u003cp\u003eApproximate values:\u003c\/p\u003e\n\u003cp\u003e0.1 ml = 0.25 mg\u003c\/p\u003e\n\u003cp\u003e0.2 ml = 0.5 mg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 0.75 mg\u003c\/p\u003e\n\u003cp\u003e0.4 ml = 1 mg\u003c\/p\u003e\n\u003cp\u003e0.5 ml = 1.25 mg\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhen dissolving 10 mg with 2 ml bacteriostatic water:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe resulting concentration is 5 mg\/ml, meaning 0.2 ml contains 1 mg.\u003c\/p\u003e\n\u003cp\u003eApproximate values:\u003c\/p\u003e\n\u003cp\u003e0.1 ml = 0.5 mg\u003c\/p\u003e\n\u003cp\u003e0.2 ml = 1 mg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 1.5 mg\u003c\/p\u003e\n\u003cp\u003e0.4 ml = 2 mg\u003c\/p\u003e\n\u003cp\u003e0.5 ml = 2.5 mg\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eScientific Publications\u003c\/h2\u003e\n\u003cp\u003eRetatrutide has also been studied in the TRIUMPH-4 clinical trial, phase 3, conducted over 68 weeks in participants with obesity or overweight and concomitant knee osteoarthritis, without diagnosed diabetes.\u003c\/p\u003e\n\u003cp\u003eAccording to the published results, the following trends were observed during the study:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAverage body weight reduction of approximately 28.7% by week 68 in the 12 mg dose group.\u003c\/li\u003e\n\u003cli\u003eSignificant reduction in pain according to the WOMAC scale, combined with improvement in physical function and daily activity.\u003c\/li\u003e\n\u003cli\u003eFavorable changes in non-HDL cholesterol, triglycerides, hsCRP, and systolic blood pressure at higher dose regimens.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eThe most commonly described adverse reactions in scientific literature are related to the gastrointestinal system.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eThese are typically dose-dependent and may include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003enausea, vomiting, diarrhea, or constipation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003edecreased appetite\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003ebloating, feeling of heaviness, and abdominal discomfort\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003eLess frequently, publications also discuss potentially more serious risks, including:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003echolelithiasis, especially with rapid body weight reduction\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003ehypoglycemia when combined with antidiabetic therapies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003e\u003cem\u003e\u003cspan class=\"s1\"\u003eThe information is summarized based on available scientific publications and clinical observations. It is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"PurePeptide","offers":[{"title":"5mg","offer_id":53386107289943,"sku":null,"price":69.0,"currency_code":"EUR","in_stock":true},{"title":"10mg","offer_id":53386107322711,"sku":null,"price":119.0,"currency_code":"EUR","in_stock":true},{"title":"30mg","offer_id":53386107355479,"sku":null,"price":219.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/Reta_5mg.png?v=1779544825","url":"https:\/\/purepeptide.eu\/products\/retatrutid-c","provider":"PurePeptide","version":"1.0","type":"link"}